- Home
- MCRI vs AXGN Comparison
MCRI vs AXGN Comparison
Compare MCRI & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCRI | AXGN |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | MCRI | AXGN |
|---|---|---|
| Price | $89.67 | $34.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $100.00 | $33.67 |
| AVG Volume (30 Days) | 70.8K | ★ 891.3K |
| Earning Date | 02-04-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.41 | N/A |
| Revenue | ★ $539,635,000.00 | $214,709,000.00 |
| Revenue This Year | $6.34 | $21.87 |
| Revenue Next Year | $3.59 | $15.69 |
| P/E Ratio | $20.50 | ★ N/A |
| Revenue Growth | 4.61 | ★ 18.72 |
| 52 Week Low | $69.99 | $9.22 |
| 52 Week High | $113.88 | $34.71 |
Technical Indicators
Market Signals| Indicator | MCRI | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 35.40 | 64.42 |
| Support Level | $88.61 | $31.50 |
| Resistance Level | $91.83 | $33.57 |
| Average True Range (ATR) | 1.94 | 1.60 |
| MACD | -0.27 | 0.01 |
| Stochastic Oscillator | 18.74 | 95.44 |
Price Performance
Historical ComparisonAbout MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.